Natera Inc. Prepares for Q1 2025 Earnings, Highlights Advances in Diagnostic Testing and Breast Cancer MRD Leadership
Natera Inc. is gearing up for its Q1 2025 earnings release, with analysts and investors eagerly awaiting insights into the company’s financial performance and its advancements in precision medicine and diagnostic solutions.
2 minutes to read